OTCMKTS:SDZNY Sandoz Group (SDZNY) Stock Price, News & Analysis $86.43 -0.12 (-0.14%) As of 09/23/2026 03:56 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartNews and TrendsShort Interest About Sandoz Group Stock (OTCMKTS:SDZNY) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Sandoz Group alerts:Sign Up Key Stats Today's Range$85.94▼$87.3750-Day Range$77.92▼$93.0152-Week Range$55.42▼$94.15Volume28,430 shsAverage Volume22,497 shsMarket Capitalization$38.03 billionP/E RatioN/ADividend Yield0.71%Price TargetN/AConsensus RatingStrong Buy Company Overview Sandoz Group AG is a Switzerland-based pharmaceutical company focused on developing, manufacturing and supplying generic and biosimilar medicines. Its portfolio includes products across areas such as anti-infectives, immunology, oncology, ophthalmology, respiratory care and cardiovascular medicine, as well as injectable and specialty pharmaceuticals. The company traces its origins to Sandoz, founded in Basel in 1886, and became an independent business through its separation from Novartis in 2023. Sandoz shares began trading independently on the SIX Swiss Exchange in October 2023, while the company’s American depositary shares trade over the counter in the United States under the symbol SDZNY. Headquartered in Basel, Switzerland, Sandoz serves patients and healthcare providers in more than 150 countries through a global network of manufacturing, research and commercial operations. The company’s business emphasizes expanding access to lower-cost medicines and advancing biosimilars, which are biologic medicines designed to be highly similar to approved reference products.AI Generated. May Contain Errors. Read More Sandoz Group Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks31st Percentile Overall ScoreSDZNY MarketRank™: Sandoz Group scored higher than 31% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.0 / 5Analyst RatingStrong Buy Consensus RatingSandoz Group has received a consensus rating of Strong Buy. The company's average rating score is 3.60, and is based on 4 strong buy ratings, no buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageSandoz Group has only been the subject of 1 research reports in the past 90 days.Read more about Sandoz Group's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings Growth12.32% Earnings GrowthEarnings for Sandoz Group are expected to grow by 12.32% in the coming year, from $4.14 to $4.65 per share.Price to Earnings Growth RatioSandoz Group has a PEG Ratio of 1.73. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioSandoz Group has a P/B Ratio of 4.05. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted0.03% of the float of Sandoz Group has been sold short.Short Interest Ratio / Days to CoverSandoz Group has a short interest ratio ("days to cover") of 4.12.Change versus previous monthShort interest in Sandoz Group has recently increased by 2.46%, indicating that investor sentiment is decreasing. Dividend0.8 / 5Dividend StrengthWeak Dividend YieldSandoz Group has a dividend yield of 0.71%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthSandoz Group does not have a long track record of dividend growth.Dividend SustainabilityBased on earnings estimates, Sandoz Group will have a dividend payout ratio of 13.12% next year. This indicates that Sandoz Group will be able to sustain or increase its dividend.Read more about Sandoz Group's dividend. News and Social Media2.7 / 5News Sentiment0.38 News SentimentSandoz Group has a news sentiment score of 0.38. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.50 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 7 news articles for Sandoz Group this week, compared to 1 article on an average week.Search Interest4 people have searched for SDZNY on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Sandoz Group insiders have not sold or bought any company stock.Percentage Held by Institutions0.05% of the stock of Sandoz Group is held by institutions.Read more about Sandoz Group's insider trading history. Receive SDZNY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sandoz Group and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SDZNY Stock News HeadlinesErste Group Bank Raises Earnings Estimates for Sandoz GroupSeptember 22 at 7:13 AM | americanbankingnews.comSandoz Partners With MAbxience On Emicizumab Biosimilar; Pipeline Reaches 40 AssetsSeptember 18, 2026 | rttnews.comHas Dylan Jovine lost his mind?SpaceX just signed a deal JPMorgan says could unlock the next phase of the space economy, putting the company on a path toward a 10 trillion valuation. But analyst Dylan Jovine says the biggest winner won't be SpaceX itself. He's identified a small firm, less than half a percent SpaceX's size, that partnered with it directly. An upcoming NASA announcement could be the catalyst. Jovine previously flagged Rocket Lab before it climbed from under 4 dollars to over 151.September 24 at 1:00 AM | Behind the Markets (Ad)Sandoz Wins Canadian Marketing Approval For Generic Semaglutide InjectionSeptember 18, 2026 | rttnews.commAbxience and Sandoz Sign a Collaboration Agreement to Advance Biosimilar Access WorldwideSeptember 18, 2026 | prnewswire.comSandoz Gets Canada Approval for Generic Version of OzempicSeptember 18, 2026 | wsj.comErste Group Bank Lifts Earnings Estimates for Sandoz GroupSeptember 13, 2026 | americanbankingnews.comSandoz Group AG (SDZNY) Analyst/Investor Day TranscriptSeptember 9, 2026 | seekingalpha.comSee More Headlines SDZNY Stock Analysis - Frequently Asked Questions How have SDZNY shares performed this year? Sandoz Group's stock was trading at $72.79 on January 1st, 2026. Since then, SDZNY stock has increased by 18.7% and is now trading at $86.43. How do I buy shares of Sandoz Group? Shares of SDZNY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today9/24/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolOTCMKTS:SDZNY CIK1992829 Webwww.sandoz.com Phone41-61-324-11-11FaxN/AEmployees23,567Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E Ratio20.88 P/E Growth1.73Net IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio0.53 Current Ratio1.18 Quick Ratio0.77 Sales & Book Value Annual Sales$11.09 billion Price / Sales3.43 Cash Flow$3.61 per share Price / Cash Flow23.97 Book Value$21.33 per share Price / Book4.05Miscellaneous Outstanding Shares440,000,000Free FloatN/AMarket Cap$38.03 billion OptionableNot Optionable Beta0.57 The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (OTCMKTS:SDZNY) was last updated on 9/24/2026 by MarketBeat.com Staff. From Our PartnersHow to get a stake in Anthropic — before the IPOAnthropic, the maker of Claude AI, has reportedly filed for an IPO that could arrive as early as October. Its ...Weiss Ratings | SponsoredWhy I believe the AI market will split in Q4Matt McCall, who recommended Nvidia near $6 a share, says the AI market is splitting in two - just like the do...The Oxford Club | SponsoredShocking new footage just releasedGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...Digest Publishing | SponsoredBarricks gold output fell from 2 million ounces to 719000Barrick's gold production has plunged from 2 million ounces to just 719,000, leaving the world's second-larges...Golden Portfolio | SponsoredMajor Buy Alert Issued for September 30thKeith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...TradeSmith | SponsoredIf you keep cash in a U.S. bank account… read this NOWSince 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every d...Banyan Hill Publishing | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredOn October 7th, your “safest” assets are at riskJeff Brown called Nvidia's rise of over 27,000 percent and warned in early 2024 that inflation would outlast W...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sandoz Group AG Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Sandoz Group With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
